Skip to content

ARJURO

Absorbed by MULTIPHARMA on 13-06-2024 KBO/BCE: BE 0860.649.821

Lifetime

18 annual accounts with figures on one time axis, 20 filings since 2004
peak of €320,425 in 2007
€78,869▼ 0.4%
lowest -€68,151 in 2012
€49,927▲ 5.3%
peak of €170,216 in 2023
€170,216▲ 41.5%
€39,042▼ 5.0%
peak of 2 FTE in 2006
-not published
Board2 names since 2017
1 director
Owners3 names in the annual accounts
100% and 1 other
Documentsfilings and deeds
24-07-20247 days before the deadline
2023financial year
reappointed as statutory auditor 27-12Equity from €120,289 to €170,216Cash from €30,732 to €12,659

Key points

from the 2023 annual accounts, the last ones filed

Profit

9 years
201820192020202120222023

9 profitable years in a row. Profit of €49,927 in financial year 2023.

Liquidity

5.36 was 3.93 in 2022

Short-term debts fell from €41,102 to €39,042.

Filings

20 annual accounts since 2004
AprilJune31 JulyOctober2005201020152020

Four of the last ten came late. The 2014 accounts came in latest, 88 days after the end of the period.

Board and ownership

Director, since 01-01-2021
Auditor,
Board & ownership

Recent changes

Merger: absorbed by MULTIPHARMA Dissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares · General meeting of 13-06-2024 · Gazette deed
Merger proposal: to be absorbed by MULTIPHARMA Gazette deed
reappointed as statutory auditor acts as permanent representative · General meeting of 08-06-2023 · Gazette deed
resigns as director appointed as director · General meeting of 03-12-2020 · Gazette deed
All 40 events

Official details

Source: KBO
Status
Absorbed by MULTIPHARMAmerger by absorption, April 2024
Activity
“A) Het verlenen van adviezen van financiële, technische, commerciële of administratieve aard, in de…” (deed in French)From the articles, 9 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2023

≈ €230,000estimated
€209,258▲ 29.7%
Filing
Filed on 24-07-2024
Financials

Insights on ARJURO

Absorbed by MULTIPHARMA in April 2024. The last annual accounts are for financial year 2023. The company was dissolved without liquidation.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ARJURO

What is the company number of ARJURO?
The company number of ARJURO is 0860.649.821. The VAT number is the same number with BE in front: BE 0860.649.821.
What is the legal form of ARJURO?
The KBO register gives ARJURO the legal form “SRL”.
Is ARJURO still active?
No. Absorbed in a merger on 13-06-2024.Company details
What is the turnover of ARJURO?
The turnover in financial year 2023 is about €230,000. This figure is estimated from the gross margin of €78,869 and 992 comparable companies of the same size. It probably lies between €140,000 and €460,000. It is a rough estimate.Financials
Is ARJURO profitable?
In financial year 2023, ARJURO made a profit of €49,927.
Where can I find the annual accounts of ARJURO?
ARJURO filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

Keep this company with today's facts in a case file.